Vaseretic (Valeant Pharmaceuticals North America LLC)
Welcome to the PulseAid listing for the Vaseretic drug offered from Valeant Pharmaceuticals North America LLC. This Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Valeant Pharmaceuticals North America LLC |
NON-PROPRIETARY NAME: | enalapril maleate and hydrochlorothiazide |
SUBSTANCE NAME: | ENALAPRIL MALEATE; HYDROCHLOROTHIAZIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1986-10-31 |
END MARKETING DATE: | 0000-00-00 |
Vaseretic HUMAN PRESCRIPTION DRUG Details:
Item Description | Vaseretic from Valeant Pharmaceuticals North America LLC |
LABELER NAME: | Valeant Pharmaceuticals North America LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 10; 25(mg/1; mg/1) |
START MARKETING DATE: | 1986-10-31 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0187-0146_9d921535-a7ec-4b09-b8b4-61a94a3f30c7 |
PRODUCT NDC: | 0187-0146 |
APPLICATION NUMBER: | NDA019221 |
Other ENALAPRIL MALEATE; HYDROCHLOROTHIAZIDE Pharmaceutical Manufacturers / Labelers: